Literature DB >> 12503886

Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles.

Akihisa Fujimoto1, Yutaka Osuga, Toshihiro Fujiwara, Tetsu Yano, Osamu Tsutsumi, Mikio Momoeda, Koji Kugu, Kaori Koga, Yutaka Morita, Osamu Wada, Yuji Taketani.   

Abstract

PURPOSE: To investigate how late-midluteal estradiol levels relate to the pregnancy outcome in IVF cycles, and to assess whether human chorionic gonadotropin (hCG) for luteal support benefits the pregnancy outcome of patients with low late-midluteal estradiol levels.
METHODS: The pregnancy rate of 436 women undergoing first IVF cycles with long protocol and luteal support with progesterone alone were analyzed. Unsuccessful women with low late-midluteal estradiol levels (< 100 pg/mL) proceeded with the exploratory second IVF cycles where they were randomly given with either progesterone alone (P protocol) or hCG +progesterone (P+hCG protocol) for luteal support.
RESULTS: Pregnancy rate in women with low late-midluteal estradiol levels was significantly lower compared to that with medium (100-500 pg/mL) and high (> 500 pg/mL) levels (13.3, 26.8, and 36.3%, respectively). P+hCG protocol increased late-midluteal estradiol levels and produced a significantly higher pregnancy rate (31.7%) than P protocol (13.7%).
CONCLUSIONS: hCG in combination with progesterone for luteal support was suggested to benefit women undergoing IVF with low late-midluteal estradiol levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503886      PMCID: PMC3455835          DOI: 10.1023/a:1021207014429

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  13 in total

1.  High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles.

Authors:  E H Yu Ng; W S Yeung; E Yee Lan Lau; W W So; P C Ho
Journal:  Hum Reprod       Date:  2000-02       Impact factor: 6.918

2.  Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome.

Authors:  F I Sharara; H D McClamrock
Journal:  Hum Reprod       Date:  1999-11       Impact factor: 6.918

3.  Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.

Authors:  J Buvat; G Marcolin; C Guittard; J C Herbaut; A L Louvet; J L Dehaene
Journal:  Fertil Steril       Date:  1990-03       Impact factor: 7.329

4.  Luteal phase serum estradiol and progesterone in in vitro fertilization.

Authors:  S Muasher; A A Acosta; J E Garcia; G S Jones; H W Jones
Journal:  Fertil Steril       Date:  1984-06       Impact factor: 7.329

5.  Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone.

Authors:  P Claman; M Domingo; A Leader
Journal:  Hum Reprod       Date:  1992-04       Impact factor: 6.918

6.  A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation.

Authors:  J Smitz; C Bourgain; L Van Waesberghe; M Camus; P Devroey; A C Van Steirteghem
Journal:  Hum Reprod       Date:  1993-01       Impact factor: 6.918

7.  Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.

Authors:  D de Ziegler; C Bergeron; C Cornel; D A Medalie; M R Massai; E Milgrom; R Frydman; P Bouchard
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

8.  Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program.

Authors:  K A Hutchinson-Williams; B Lunenfeld; M P Diamond; G Lavy; S P Boyers; A H DeCherney
Journal:  Fertil Steril       Date:  1989-09       Impact factor: 7.329

9.  The early luteal phase in successful and unsuccessful implantation after IVF-ET.

Authors:  L Nylund; C Beskow; K Carlström; B Fredricsson; O Gustafson; N O Lunell; A Pousette; L Rosenborg; H Slotte; E Akerlöf
Journal:  Hum Reprod       Date:  1990-01       Impact factor: 6.918

10.  Luteal phase support and severe ovarian hyperstimulation syndrome.

Authors:  N McClure; J Leya; E Radwanska; R Rawlins; R V Haning
Journal:  Hum Reprod       Date:  1992-07       Impact factor: 6.918

View more
  4 in total

Review 1.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

Review 2.  Endocrine factors modulating immune responses in pregnancy.

Authors:  Anne Schumacher; Serban-Dan Costa; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

3.  Use of Follicular Output Rate to Predict Intracytoplasmic Sperm Injection Outcome.

Authors:  Rehana Rehman; Rozina Mustafa; Mukhtiar Baig; Sara Arif; Muhammad Faisal Hashmi
Journal:  Int J Fertil Steril       Date:  2016-06-01

4.  Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.

Authors:  Rodopiano S Florêncio; Melaynne S B Meira; Marcos V da Cunha; Mylena N C R Camarço; Eduardo C Castro; Marta C C F Finotti; Vinicius A de Oliveira
Journal:  JBRA Assist Reprod       Date:  2018-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.